Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2014 2
2015 4
2016 6
2017 2
2018 3
2019 6
2020 10
2021 16
2022 16
2023 17
2024 11
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
HIV infection.
Bekker LG, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, Masters MC, Lazarus JV. Bekker LG, et al. Among authors: mgodi n. Nat Rev Dis Primers. 2023 Aug 17;9(1):42. doi: 10.1038/s41572-023-00452-3. Nat Rev Dis Primers. 2023. PMID: 37591865 Review.
Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial.
Delany-Moretlwe S, Hughes JP, Bock P, Ouma SG, Hunidzarira P, Kalonji D, Kayange N, Makhema J, Mandima P, Mathew C, Spooner E, Mpendo J, Mukwekwerere P, Mgodi N, Ntege PN, Nair G, Nakabiito C, Nuwagaba-Biribonwoha H, Panchia R, Singh N, Siziba B, Farrior J, Rose S, Anderson PL, Eshleman SH, Marzinke MA, Hendrix CW, Beigel-Orme S, Hosek S, Tolley E, Sista N, Adeyeye A, Rooney JF, Rinehart A, Spreen WR, Smith K, Hanscom B, Cohen MS, Hosseinipour MC; HPTN 084 study group. Delany-Moretlwe S, et al. Among authors: mgodi n. Lancet. 2022 May 7;399(10337):1779-1789. doi: 10.1016/S0140-6736(22)00538-4. Epub 2022 Apr 1. Lancet. 2022. PMID: 35378077 Free PMC article. Clinical Trial.
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS; HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams. Corey L, et al. Among authors: mgodi nm. N Engl J Med. 2021 Mar 18;384(11):1003-1014. doi: 10.1056/NEJMoa2031738. N Engl J Med. 2021. PMID: 33730454 Free PMC article. Clinical Trial.
Author Correction: HIV infection.
Bekker LG, Beyrer C, Mgodi N, Lewin SR, Delany-Moretlwe S, Taiwo B, Masters MC, Lazarus JV. Bekker LG, et al. Among authors: mgodi n. Nat Rev Dis Primers. 2023 Sep 11;9(1):48. doi: 10.1038/s41572-023-00464-z. Nat Rev Dis Primers. 2023. PMID: 37696843 No abstract available.
Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development.
Hesselman MC, Zeeb M, Rusert P, Pasin C, Mamrosh J, Kariuki S, Pichler I, Sickmann M, Kaufmann MM, Schmidt D, Friedrich N, Metzner KJ, Rindler A, Kuster H, Adams C, Thebus R, Huber M, Yerly S, Leuzinger K, Perreau M, Koller R, Dollenmaier G, Frigerio S, Westfall DH, Deng W, deCamp AC, Juraska M, Edupuganti S, Mgodi N, Murrell H, Garrett N, Wagh K, Mullins JI, Williamson C, Moore PL, Günthard HF, Kouyos RD, Trkola A. Hesselman MC, et al. Among authors: mgodi n. Cell Host Microbe. 2025 Feb 12;33(2):279-293.e6. doi: 10.1016/j.chom.2025.01.004. Epub 2025 Feb 4. Cell Host Microbe. 2025. PMID: 39909038 Free article.
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084.
Delany-Moretlwe S, Hanscom B, Guo X, Nkabiito C, Mandima P, Nahirya PN, Mpendo J, Bhondai-Mhuri M, Mgodi N, Berhanu R, Farrior J, Piwowar-Manning E, Ford SL, Hendrix CW, Rinehart AR, Rooney JF, Adeyeye A, Landovitz RJ, Cohen MS, Hosseinipour MC, Marzinke MA; HPTN 084 Study Team. Delany-Moretlwe S, et al. Among authors: mgodi n. J Int AIDS Soc. 2025 Jan;28(1):e26401. doi: 10.1002/jia2.26401. J Int AIDS Soc. 2025. PMID: 39748218 Free PMC article. Clinical Trial.
Where are the pregnant and breastfeeding women in new pre-exposure prophylaxis trials? The imperative to overcome the evidence gap.
Joseph Davey DL, Bekker LG, Bukusi EA, Chi BH, Delany-Moretlwe S, Goga A, Lyerly AD, Mgodi NM, Mugo N, Myer L, Noguchi LM, Stranix-Chibanda L, Slack C, Pintye J. Joseph Davey DL, et al. Among authors: mgodi nm. Lancet HIV. 2022 Mar;9(3):e214-e222. doi: 10.1016/S2352-3018(21)00280-0. Epub 2022 Jan 25. Lancet HIV. 2022. PMID: 35090604 Free PMC article. Review.
Safety data needed for concurrent use of ARV-based PrEP.
Dunbar MS, Rodrigues J, Chatani M, Baeten JM, Hendrix CW, Palanee-Phillips T, van der Straten A, Mgodi N, Brown E, Makura C, Namwanje S, Torjesen K. Dunbar MS, et al. Among authors: mgodi n. Lancet HIV. 2022 Nov;9(11):e742-e744. doi: 10.1016/S2352-3018(22)00256-9. Epub 2022 Sep 27. Lancet HIV. 2022. PMID: 36179732 No abstract available.
Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial.
Stranix-Chibanda L, Hamilton EL, Ngo J, Jiao Y, Hanscom B, Choudhury RP, Agyei Y, Piwowar-Manning E, Marzinke M, Delany-Moretlwe S, Mgodi N, Siziba B, Naidoo I, Gati Mirembe B, Kamira B, McCoig C, Adeyeye A, Spiegel HML, Hosek S; HPTN 084-01 Protocol Team. Stranix-Chibanda L, et al. Among authors: mgodi n. Lancet HIV. 2025 Apr;12(4):e252-e260. doi: 10.1016/S2352-3018(24)00310-2. Epub 2025 Mar 12. Lancet HIV. 2025. PMID: 40088909 Free PMC article. Clinical Trial.
103 results